The DRCR Retina Network is undertaking research to develop preventive strategies for diabetic eye disease, explained Jennifer K. Sun, MD, MPH, associate professor of ophthalmology and chief of the Center for Clinical Eye Research and Trials, Harvard Medical School; and chair, DRCR Retina Network.
The DRCR Retina Network is undertaking research to develop preventive strategies for diabetic eye disease. One study is analyzing fenofibrate, which is typically used for cholesterol management, to evaluate how it protects against retinopathy worsening, explained Jennifer K. Sun, MD, MPH, associate professor of ophthalmology and chief of the Center for Clinical Eye Research and Trials, Harvard Medical School; and chair, DRCR Retina Network.
Transcript
What trials are ongoing in the DRCR Retina Network that you want to highlight?
We're very interested in understanding, now that we have good treatments for late-stage disease—in terms of proliferative diabetic retinopathy and diabetic macular edema—how do we develop preventive strategies? One of the studies that is currently up and recruiting is a study looking at fenofibrate use for prevention of retinopathy worsening in early-stage diabetic retinopathy. There are a couple of large cardiovascular studies that have suggested that patients on fenofibrate, which has been typically used for cholesterol management—it's been around for decades, and it's pretty well tolerated, it's cheap, because it's off patent, so it's readily available—these studies have suggested that patients on fenofibrate seem to be protected against retinopathy worsening.
Nonetheless, in general, physicians have not used fenofibrate as first-line treatment for diabetic retinopathy, you know, early-stage disease. We're starting a study that will follow patients for 4 years—randomize them to fenofibrate vs placebo. There are a number of studies that are also ongoing within that study looking at how we look at visual function in these patients through contrast sensitivity, through visual fields, and development of imaging biomarkers of disease progression.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen